REFERENCES
- D'Angio G., Farber S., Maddock C. Potentiation of X-Ray effects by actinomycin D. Radiology 1959; 73: 175–177
- Tan C., Dargeon H., Burchenal J. The effect of actinomycin D on cancer in childhood. Paediatrics 1959; 24: 544–561
- Burdon J., Bell R., Sullivan J., Henderson M. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA 1978; 239: 931
- Camidge R., Price A. Characterising the phenomenon of radiation recall dermatitis. Radiother Oncol 2001; 59: 237–245
- Ristic B. Radiation recall dermatitis. Int J Dermatology 2004; 43: 627–631
- Castellano D., Hitt R., Cortes-Funes H., Romero A., Rodriguez-Peralto J. Radiation recall reaction induced by gemcitabine. JCO 2000; 18(3)693–698
- Huang J., Wu C., Shih I., Lai P. Complications mimicking lupus flare-up in a uremic patient undergoing pegylated liposomal doxorubicin therapy for cervical cancer. Anticancer Drugs, 2004; 15: 239–241
- Jimeno A., Ciruelos E., Castellano D., Caballero B., Rodriguez-Peralto J., Cortes-Funes H. Radiation recall dermatitis induced by pegylated liposomal doxorubicin. Anticancer Drugs 2003; 14: 575–576
- Muggia F. Re: Radiation recall dermatitis induced by pegylated liposomal doxorubicin. Anticancer Drugs 2004; 15: 35
- Smith K., Germain M., Skelton H. Histopathologic features seen with radiation recall or enhancement eruptions. J Cutaneous Med Sur 2002; 6: 535–540
- Kron T., Ostwald P. Skin exit dose in megavoltage X-ray beams determined by means of a parallel ionisation chamber (Attix chamber). Med Phy 1995; 22(5)577–579
- Yeo W., Leung S., Johnson P. Radiation-recall dermatitis with doecetaxel: establishment of a requisite radiation threshold. Euro J Cancer 1997; 33(4)698–699
- Stelzer K., Griffin T., Koh W. Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 1993; 71(4)1322–1325